Nath Bio-Genes (India) Ltd - 537291 - Reg. 34 (1) Annual Report.
Annual Report for FY2317-06-2023
Nath Bio-Genes (India) Ltd - 537291 - Notice Of 30Th Annual General Meeting And Annual Report For FY23.
Notice of 30th Annual General Meeting and Annual Report for FY23.17-06-2023
Nath Bio-Genes (India) Ltd - 537291 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial year ended 31st March 2023.27-05-2023
Nath Bio-Genes (India) Ltd - 537291 - Intimation For Change In Record Date
Intimation for Change in Book Closure and Record Date23-05-2023
Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Meeting Updates
Intimation for Change in Date of Annual General Meeting23-05-2023
Nath Bio-Genes (India) Ltd - 537291 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyNath Bio-Genes (India) Ltd 2CIN NO.L01110MH1993PLC072842 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: DHIRAJ RATHI Designation: COMPANY SECRETARY EmailId: investor@nathbiogenes.com Name of the Chief Financial Officer: DEVINDER KHURANA Designation: CHIEF FINANCIAL OFFICER EmailId: investor@nathbiogenes.com Date: 28/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.28-04-2023
Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Earning Call Transcript27-04-2023
Nath Bio-Genes (India) Ltd - 537291 - Intimation For Book Closure And Record Date.
Book Closure and record date for upcoming AGM25-04-2023
Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Transcript of Conference Call held on 24th April 202325-04-2023
Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on Audited Financial Results as of 31st March 2023.22-04-2023